Skip to content

Released Nov 10, 2020, before the open

10-Q filed Nov 10, 2020, 41 days after period end · 0001104659-20-123339

Q3 2020 · 10-Q
Revenue$0.00−100.0% vs Q3 2019no prior Q2 2020 on file
Net Income-$4.31MN/M vs Q3 2019N/M vs Q2 2020
EPS Diluted-$0.07N/M vs Q3 2019N/M vs Q2 2020
Operating Income-$4,375,056N/M
Operating Cash Flowderived-$4,163,559N/M

What the release said

No earnings release is on file for this quarter. Its figures came with the 10-Q.

Same quarter

MetricQ3 2020Q3 2019Q3 2018Q3 2017
Revenue$0.00$164.99K$0.00$0.00
Net Income-$4.31M-$3.06M-$2.46M-$4.70M
EPS Diluted-$0.07-$0.12-$0.12-$0.22

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Lipocine Inc. · CIK 1535955 · Engraved from SEC EDGAR